Public transportation provides an opportunity to incorporate physical activity into journeys, but potential health impacts have not been systematically examined. We searched the literature for articles on public transportation and health published through December 2017 using Google (Google Inc., Mountain View, California), 5 medical databases, and 1 transportation-related database. We identified longitudinal studies which examined associations between public transportation and cardiometabolic health (including adiposity, type 2 diabetes mellitus, and cardiovascular disease). We assessed study quality using the Newcastle-Ottawa Scale for cohort studies and performed meta-analyses where possible. Ten studies were identified, 7 investigating use of public transportation and 3 examining proximity to public transportation. Seven studies used individual-level data on changes in body mass index (BMI; weight (kg)/height (m) 2 ), with objective outcomes being measured in 6 studies. Study follow-up ranged from 1 year to 10 years, and 3 studies adjusted for nontransportation physical activity. We found a consistent association between use of public transportation and lower BMI. Meta-analysis of data from 5 comparable studies found that switching from automobile use to public transportation was associated with lower BMI (−0.30 units, 95% confidence interval: −0.47, −0.14). Few studies have investigated associations between public transportation use and nonadiposity outcomes. These findings suggest that sustainable urban design which promotes public transportation use may produce modest reductions in population BMI. active travel; adiposity; cardiometabolic health; physical activity; systematic reviews; transportation Abbreviations: BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease.
Governments and city mayors worldwide increasingly recognize the importance of investing in local public transportation systems. For example, bus rapid transit systems have been introduced in cities in the United States, Europe, and Latin America, and many countries have recently made major investments in rail networks (1) . Such actions directly deliver progress towards United Nations Sustainable Development Goal 11, which aims to "create safe, inclusive, resilient and sustainable cities, including through affordable, accessible and expanded public transportation systems" (2) . Furthermore, investment in public transportation systems may also reduce carbon emissions, improve air quality, and increase economic activity through reduced congestion and improved connectivity, thus contributing to the achievement of several other Sustainable Development Goals (2) (3) (4) .
Public transportation systems may substantially influence physical activity at the population level, as users commonly walk or cycle to transportation stops and interchanges. In a 2012 review, Rissel et al. (5) found that use of public transportation was associated with 8-33 minutes of physical activity per day, with one study finding that 29% of commuters achieved 30 minutes of daily physical activity as part of public transportation use (6) . More recent studies using objective measures of physical activity found that public transportation use was associated with 10.2 minutes of moderate-to-vigorous physical activity per trip (7, 8) . These findings are important given that public transportation use is typically more prevalent than walking or cycling for transportation; for example, in England and Wales, public transportation accounts for 16% of commutes, as compared with 11% for walking and 3% for cycling (9, 10) .
Encouraging public transportation use may be an especially effective approach to increasing physical activity among the least active members of society (11) and may be equity-enhancing, since minority ethnic and low-income groups with poorer cardiometabolic health profiles are, on average, more frequent users of public transportation (12, 13) .
Most existing evidence is focused on the cardiometabolic benefits of walking and cycling for transportation (14, 15) . This evidence shows that people who walk or cycle for transportation have lower adiposity, cardiovascular disease (CVD) risk, and CVD mortality (15) (16) (17) (18) (19) (20) . To our knowledge, the relationship between public transportation use and cardiometabolic outcomes has not previously been systematically assessed. We thus conducted a systematic review of studies examining associations between public transportation (including trains, buses, and subway systems) and cardiometabolic health outcomes.
METHODS
The protocol for this review was registered with the International Prospective Register of Systematic Reviews (identification number CRD42016048427).
Information sources
Studies were identified using published and gray literature databases, Internet searches (Google; Google Inc., Mountain View, California), and reference lists of included studies. The electronic databases searched were MEDLINE (National Library of Medicine, Bethesda, Maryland), Embase (Elsevier BV, Amsterdam, the Netherlands), the Transport Database (Organisation for Economic Cooperation and Development, Paris, France, and Transportation Research Board, Washington, DC), Scopus (Elsevier BV), the Cochrane Library (The Cochrane Collaboration, London, United Kingdom), and opengrey.eu (Institut de l'Information Scientifique et Technique, Vandoeuvre-lès-Nancy, France). No restrictions were placed on the dates of publication. Database searches took place in December 2017. The search strategy used in MEDLINE is given in Web Appendix 1 (available at https://academic.oup.com/aje), with adapted searches being used in the other databases and simplified searches used in opengrey.eu and Google. In general, keywords for identifying articles related to public transportation included "public transportation," "bus," "train," "transit," "subway," and "commute," and keywords for identifying cardiometabolic articles were "cardiovascular," "diabetes," "hypertension," "mortality," "obesity," "adiposity," "body fat," and "body mass index."
Initial study eligibility was assessed by reviewing titles and abstracts and was carried out independently by 2 of the authors (R.P./A.A.L.). These 2 authors then independently carried out full text screening, with any disagreement being resolved through discussion.
Inclusion criteria
In order to maximize the number of studies returned, all randomized controlled trials, quasiexperimental studies, and longitudinal observational studies were eligible for inclusion. We did not include cross-sectional studies, however, in order to increase causal inference and reduce potential bias from unobserved confounding (21) . We included studies that assessed public transportation exposure, including public transportation use, change in public transportation use, or access to public transportation (e.g., proximity of bus stops). Eligible comparator groups included users of other modes of travel, such as automobile drivers, and persons at greater distance from bus stops. Studies without comparators were excluded. Eligible cardiometabolic outcomes included CVD mortality, diagnosis of CVD, type 2 diabetes mellitus, dysglycemia (e.g., elevated blood glucose level, insulin resistance, glucose intolerance), dyslipidemia (e.g., elevated triglyceride or low density lipoprotein level, depressed high density lipoprotein level, hypertension/blood pressure), and measures of adiposity (e.g., body mass index (BMI; calculated as weight (kg)/ height (m) 2 ), percentage of body fat, waist circumference, waist: hip ratio, and height:weight ratio). We included both selfreported and objectively measured outcomes. Any study population of adults and/or children aged ≥5 years was included. We only included studies published in English.
Data extraction
Data extracted included information on the characteristics of study participants (including age, location, and proportion male), year of publication, study size, length of follow-up, sample selection, cohort/study names, exposure, outcome, covariates, analysis type, and effect estimates. Data were extracted by one author (R.P.) and checked by a second (A.A.L.). Where multiple studies used the same data source, we included the analysis using the most recent data.
Quality assessment
Studies were assessed for risk of bias using criteria derived from the Newcastle-Ottawa Scale for cohort studies. The NewcastleOttawa Scale is recommended by the Cochrane Collaboration for use with nonrandomized studies and was applicable to the study designs found (22, 23) . Because of concerns about the validity of calculating overall risk-of-bias scores for heterogeneous studies, including concerns that the tool itself might introduce bias, we chose not to calculate an overall risk-of-bias score (24) . Instead, we assessed the risk-of-bias domains separately to identify whether studies with greater risk of bias in a particular domain had systematically different conclusions than those with lower risk. Domains of the Newcastle-Ottawa Scale include the representativeness of the exposed group, ascertainment of exposure, the presence of adjustment for covariates (especially, in this case, adjustment for nontransportation physical activity), and assessment of the outcome (e.g., objective or self-reported).
Data analysis
We summarized associations between public transportation and each outcome studied. Where different types of exposure were available for the same outcome (e.g., public transportation use vs. proximity to public transportation), their findings were compared to evaluate consistency. Where there were sufficient studies presenting comparable exposure and outcome measures, a random-effects meta-analysis was carried out using the methods suggested by DerSimonian and Laird (25) . This was possible for 5 studies that examined changes in mode of transportation and change in BMI. In order to allow comparison between studies, some harmonization was carried out as required; for example, in a study that measured distance to bus stops in miles, distance was converted to kilometers to allow comparison with other studies. I 2 was calculated to assess heterogeneity in the data; this is interpreted as the proportion of total variation in estimates that is due to heterogeneity between the studies rather than due to chance (26) . Funnel plots were used to assess reporting biases and heterogeneity in study findings attributable to study size (27) .
RESULTS

Description of included studies
We identified 40,639 studies through literature searches, of which 14,904 were duplicates (Figure 1 ). Of the remaining articles, 229 studies were retained following title and abstract screening. After full text assessment, 10 studies were included in this review. Sixty-one studies were excluded because of an unsuitable study design, of which 29 were not longitudinal. We excluded 134 studies for unsuitable exposure (predominately not assessing public transportation use specifically) and 22 for ineligible outcomes (such as physical activity energy expenditure).
All included studies were of adults (range of mean ages at baseline, 41-62 years). Six were based in the United States (28-33), 3 were from the United Kingdom (34) (35) (36) , and 1 was from China (37) ( Table 1) . No studies had been published before 2008, and 5 had been published since 2016 (28, 30, 33, 34, 37) . Seven studies investigated the direct effects of public transportation use; that is, they compared users with nonusers (28-30, 32, 34-36) . Public transportation use was assessed by means of survey questions about usual mode of commuting (30, 34, 35) or any use of public transportation (28, 29, 32, 36) . The remaining 3 studies investigated proximity to public transportation, with 1 study examining the impact of a new light rail line (33) and the other 2 investigating the distance to the nearest bus stop or route (31, 37) .
Seven studies investigated adiposity as a primary outcome and evaluated change in BMI using individual-level data (28, 31, 32, (34) (35) (36) (37) , while 2 studies investigated the percentage of obese participants in each exposure group (29, 30) . One study also assessed the odds of being obese for public transportation users and nonusers (36) . Waist circumference, in addition to BMI, was used as a measure of adiposity in 2 studies (31, 36) . The only study with an outcome other than adiposity was an ecological study comparing stroke mortality among persons living proximate to new light rail infrastructure with that among persons living farther away (33) . Eight of the studies used individual-level data (28, 29, 31, 32, (34) (35) (36) (37) , while the remaining 2 used ecological data, at the level of the US state (30) and the city neighborhood (33) .
Study quality
Information on study quality is presented in Table 1 , with additional information on quality assessments presented in Web Tables 1 and 2 and Web Appendix 2. There was a combined total of 29,021 participants in the included studies, with each study contributing between 47 and 8,028 participants, plus an additional 2 ecological studies. Three studies provided nationally representative samples using large-scale population surveys, reducing the risk of selection bias (30, 35, 36) , while 5 studies selected participants on the basis of proximity to public transportation infrastructure (28, 29, 32, 33, 37) . Control groups were drawn from the same population as the exposed groups in all but 1 case (33) . Eight studies examined self-reported public transportation use ascertained by structured interview, which is potentially subject to recall bias (28-30, 32, 34-37) . The exceptions were those which used proximity to new infrastructure and compared proximate persons with those less proximate (33) and those in which exposure was distance to the nearest bus stop, measured using geographic information systems (31) .
Adiposity was measured objectively in 5 studies (28, 29, 31, 34, 36) , with 4 using self-reported data (30, 32, 35, 37) , which are known to be susceptible to misclassification bias (38) . Stroke mortality data were obtained from a death registry, with cause of death assessed using International Classification of Diseases, Tenth Revision, codes I60-I69 (33, 39) . One individual-level study pooled obesity data from both time points, which increased the risk of reverse causality or selection bias (e.g., generally healthier people choosing to live in an area in order to take advantage of proximity to public transportation) (29) .
Adjustment for important potential confounders such as nontransportation physical activity and general health was inconsistent. Three studies adjusted for nontransportation physical activity (30, 34, 37) , with 1 additional study adjusting for transportation walking (which included walking to get to destinations such as work or stores) (31) . Five studies adjusted for a measure of general health (28, 30, 31, 34, 35) , with an additional study adjusting for difficulties with Activities of Daily Living, a measure of a participant's ability to conduct basic daily self-care activities, such as getting up from a chair (36) . One ecological study adjusted for health expenditure at the state level (30) , and 2 studies adjusted for diet quality (31, 37) .
Public transportation and adiposity
Studies of public transportation use. Seven of the 10 studies investigated public transportation use and adiposity, with 6 using individual-level data and 1 using ecological data. Exposure was self-reported usual mode of commuting (e.g., bus, train) in 3 studies and whether any public transportation was used in 4 studies. In comparison with persons who never used public transportation, there was a consistent association between public transportation use and lower adiposity. Five of these 7 studies measured changes in BMI and were included in the meta-analysis of initiation of public transportation use (Figure 2) (28, 32, 34-36) . Four of these studies measured the impact of both initiating and ceasing public transportation use and therefore contributed 2 outcome data points to our meta-analysis (28, (34) (35) (36) . Results from the meta-analysis showed that initiating public transportation use was associated with a BMI reduction of 0.30 units (95% confidence interval (CI): 0.14, 0.47). The I 2 value for heterogeneity in the meta-analysis was 65.1% (Figure 2) , indicating a moderate level of between-study heterogeneity (40) . The largest change in BMI was seen in the study by MacDonald et al. (32) , the smallest of the 5 studies and the only study not to account for the baseline health status of participants, which may have increased the risk of bias. Excluding this study resulted in an estimated BMI reduction of 0.28 units (95% CI: 0.12, 0.44) and a slightly increased I 2 value of 64.6% (Web Figure 1) 
(32).
We combined a range of studies in this review, which may partly explain some heterogeneity in findings. Both US-based studies evaluated the impacts of new light rail infrastructure in proximate populations and had relatively smaller sample sizes (n = 536 and n = 301) (28, 32) than comparable United Kingdom studies, which used survey data from the general population (n = 5,861, n = 4,056, and n = 4,686) (34) (35) (36) . A funnel plot of the studies in this meta-analysis was inconclusive, with insufficient studies available for formal statistical tests (Web Figure 2) . Differences in findings may therefore have been due to national contexts, length of follow-up, or differences in study design-specifically the fact that the 2 US studies were evaluations of new infrastructure rather than studies based on the general population. The 4 studies providing 2 data points all had a smaller magnitude of change in BMI associated with initiating public transportation use than with ceasing use, although 95% confidence intervals overlapped in each case (28, (34) (35) (36) . The only studies to adjust for nontransportation physical activity provided estimates comparable with those from the other studies and similar estimates with and without adjustment: BMI change was −0.30 units (95% CI: −0.47, −0.13) with physical activity adjustment and −0.32 units (95% CI: −0.49, −0.15) without such adjustment (34) .
Three studies provided noncomparable data which could not be included in the meta-analysis (29, 30, 36) . A United Kingdom-based study found reduced odds of BMI-measured obesity among public transportation users (adjusted odds ratio = 0.79, 95% CI: 0.63, 0.98), although this association was not seen with obesity measured by waist circumference (36) . A further study found that the proportion of obese participants among non-public transportation users was 0.65 (95% CI: 0.41, 0.89), but among initiating users and continuing users the proportions were 0.26 (95% CI: 0.01, 0.51) and 0.15 (95% CI: −0.05, 0.35), respectively (29) . However, that study pooled obesity measures taken before and after public transportation use (29) , increasing the potential for both selection bias and reverse causality. The final study was an ecological comparison of 50 US states over a period of 10 years which found that higher levels of public transportation commuting in 1 year were associated with lower levels of overweight (change in prevalence: −0.32%, 95% CI: −0.05, −0.59) and obesity (−0.21%, 95% CI: −0.03, −0.39) a year later (30) . Results of this study mean that a 1% increase in public transportation commuting at the state level was associated with a 0.21% reduction in obesity prevalence.
Studies of proximity to public transportation. Two studies investigated associations between distance from the participant's home to the nearest bus route and adiposity, harmonized here for comparison to express change in adiposity per 1-km change in the distance to bus routes (Figure 2) (31, 37) . The 2 studies had divergent findings, with one study from China finding a negative association with BMI (−0.10 units, 95% CI: −0.20, −0.01) (37) and the other study, a US study, finding no association with BMI (0.01 units, 95% CI: −0.01, 0.02) or waist circumference (31) . There were several differences between these 2 studies, including the use of objectively measured exposure in the US study and self-reported distance to bus stops in the Chinese study, which is susceptible to reporting bias; participants with higher BMIs may be more likely to overestimate the distance to the nearest bus stop. The study of Chinese participants adjusted for physical exercise, while the US study adjusted for transportation walking but no other physical activity.
Public transportation and stroke mortality
One study examined the impact of a new light rail line on stroke mortality for 2 years before and after the line opened (33). This study compared daily incidence of stroke mortality among persons of all ages living within 3, 5, and 10 miles (4.8, 8, and 16 km) of the new railway line with that among persons living more than 10 miles (>16 km) away. It employed an interrupted time series design, taking account of seasonal and long-term trends, day of the week (weekday vs. weekend), and the effects of traffic pollution (as measured by acetylene concentration). Both exposure and mortality rates were measured at an area level. There were reductions in the daily total stroke mortality rate of 39.3% (95% CI: 6.8, 60.4) within 5 miles of the light rail line and 33.3% (95% CI: 10.0, 50.6) within 10 miles of the light rail line but not in control areas (>10 miles from the light rail line; −4.1%, 95% CI: −31.9, 35.1). Using the same interrupted time series model, the study also identified reductions in average atmospheric acetylene concentrations over time, which may be a potential causal mechanism for the reduction in stroke mortality found.
DISCUSSION
This systematic review of studies examining associations between public transportation use and cardiometabolic outcomes identified 10 studies. These studies present consistent evidence that initiation of public transportation use is associated with reduced adiposity. Distance from the residential address to the nearest bus route had mixed associations with adiposity. Few studies have investigated associations between public transportation use and nonadiposity outcomes.
Comparison with previous research
The association between public transportation use and adiposity identified here is perhaps unsurprising given that public transportation use is associated with increased physical activity, that is, through walking to transportation stops and interchanges. While dietary factors may be a more important determinant of adiposity, there is a large body of literature indicating that physical activity may also confer protective benefits against adiposity. The majority of previous research on the cardiometabolic benefits of transportation has focused on walking and cycling, which have been found to have greater benefits than those identified here for public transportation (14, 15) . For example, the magnitude of association we identified between public transportation use and BMI (−0.30 units, 95% CI: −0.47, −0.14) was smaller than that identified in a recent systematic review of walking interventions, which found a BMI change of −0.53 units (95% CI: −0.72, −0.35) (41). These results may be consistent with there being higher levels of physical activity among people who walk whole journeys, although this is not always the case, as many walking journeys may take place over short distances (42, 43) .
We found only 1 study on the association between public transportation use and a nonadiposity outcome (stroke), so a lack of data precluded us from making any firm conclusions regarding cardiometabolic health more generally. In contrast, walking or cycling for transportation has been found to be associated with an 11% reduction in global CVD risk (15) , and both pedestrian and cycle commuting have been associated with lower risks of CVD mortality (14) . Further research on public transportation and cardiometabolic health is needed, including studies which better quantify associated physical activity, examine dose-response relationships, and adequately control for potential confounders, including dietary intake.
Strengths and limitations
To our knowledge, this is the first systematic review that has examined associations between public transportation use and cardiometabolic health. Strengths included the use of strict inclusion criteria which excluded cross-sectional studies and identified studies with repeated measures to capture intraindividual changes in outcomes, thus minimizing the impacts of unobserved confounding (21) . While only 1 individual-level study adjusted for nontransportation physical activity, that study found an effect size comparable to that of the other studies included in this review in fully adjusted models (34) . Our search strategy was broad and covered both health and transportation databases, reducing the risk of missing potential studies. The comprehensiveness of our search strategy was enhanced by the inclusion of gray literature searches through the Transport Database, Opengrey.eu, and Google. We were able to perform metaanalysis using data from 5 of the studies. Findings from this meta-analysis were broadly consistent with those from studies that we were unable to incorporate in the meta-analysis.
This review had some limitations, however. The majority of studies assessed public transportation use by self-report, which may encourage people to overstate the amount of walking and cycling they engage in as part of transportation use (7, 8) . Nonetheless, 3 of the included studies used usual mode of commuting as the exposure, which is less likely to be subject to recall bias, although it may fail to capture the use of multiple modes within the same day or on different days of the week. Depending on the alternative travel modes used, this might lead to over-or underestimation of any associations between public transportation use and cardiometabolic health. Additionally, assessment of exposure across the studies was heterogeneous, making comparison difficult. For example, the Flint et al. study (34) combined walking, cycling, and public transportation commuters when investigating switching to and from automobile use. This may have produced a slightly higher estimate of adiposity changes, since walking and cycling commuters may experience greater benefits than public transportation commuters. BMI was used as the outcome in all studies assessing adiposity, although 2 also investigated waist circumference (31, 36) . While questions have been raised over the validity of BMI as a measure of adiposity, particularly about its accuracy across ages and ethnic groups, it remains a common metric for assessing adiposity at the population level (44, 45) .
Given the broad range of eligible outcomes, the number of included studies was low, with 9 studies investigating adiposity and 1 examining stroke mortality. There was substantial variation in the methodological quality and approach of the included studies; for example, some studies investigated intraindividual changes in outcome and some did not. In their 2008 study, Brown et al. (29) investigated change in transportation mode and BMI using measurements pooled from 2 time points, increasing the risk of reverse causality and self-selection. Statistical adjustment for potential confounders was limited in many of the included studies, with only 3 providing adjustment for nontransportation physical activity (30, 34, 37) , only 2 adjusting for diet quality (31, 37) , and only 1 adjusting for activity-limiting illnesses (36) . The included studies may have been subject to selection bias, since such studies often focus on commuter populationspersons who are employed, more affluent, healthier, and more likely to live near transportation infrastructure. Publication bias and other small-study effects are a potential concern, but insufficient data precluded formal statistical tests of this. All studies except 1 were from the United States and the United Kingdom, which differ substantially in terms of population density, intersection density, public transportation density, and level of automobile dependence (10, 46, 47) . More studies in a range of settings are required to better understand how these contextual factors may influence the relationship between transportation use and cardiometabolic health, and the generalizability of our findings to other countries is uncertain (48) (49) (50) .
Policy implications
It is expected that by 2050, 66% of the global population will be living in urban areas (51, 52) ; therefore, it is essential in future urban planning and design to create sustainable cities which facilitate healthy lives and meet Sustainable Development Goals (2). In densely populated urban areas, particularly, well-planned efficient public transportation systems can facilitate residents' travel while helping to maintain health. Concomitant benefits of switching from automobile use to public transportation include reduced traffic congestion, safe, walkable neighborhoods, and reduced emissions of carbon dioxide, nitrogen dioxide, particulate matter, and other pollutants (53, 54) . This systematic review highlights some adiposity benefits derived from public transportation use in addition to these benefits. In the English population, a BMI reduction of 0.30 units among persons initiating public transportation use is equivalent to a mean difference of 0.9 kg in men and 0.8 kg in women (55)-sufficient to be clinically relevant and greater than changes seen with many individually focused interventions (56) . Transportation planning could usefully be aimed towards encouraging increased use of public transportation by improving its availability, accessibility, and affordability in order to increase physical activity and potentially reduce adiposity (57, 58) . Additionally, any increases in physical activity from such efforts would be particularly beneficial for the most sedentary people in society (11, 59) , such as the elderly and members of some ethnic minority groups, who are less likely to reach recommended levels of physical activity from leisure-based activities but have high levels of public transportation use (60-64).
This review also highlights a lack of research into public transportation use and nonadiposity cardiometabolic health outcomes. Elevated adiposity in and of itself is only a marker of poor health, albeit one strongly linked with clinical health outcomes such as diabetes, CVD, and mortality (65) (66) (67) . We found no individual-level prospective studies examining the association between public transportation use and nonadiposity cardiometabolic health outcomes, and we found very few studies investigating this association at all, even at an ecological level (33, 68) . Further research on the health impacts of public transportation use, including the use of methods which account for selection bias and unobserved confounding and investigation of the potential effects of public transportation on incident CVD and type 2 diabetes, would be beneficial to inform policy.
Conclusion
This systematic review found that initiating public transportation use was associated with modestly lower adiposity. Little evidence was available for other outcomes. Incorporating public transportation into sustainable urban design should be considered a potential mechanism for reducing overweight and obesity in the general population.
